Neurodegeneration emerges at a cellular tipping point between aggregate accumulation and removal
Authors:
- Matthew W. CottonMCMatthew W. Cotton
- Shriram VenkatesanSVShriram Venkatesan
- Joseph S. BeckwithJBJoseph S. Beckwith
- Dorothea BökenDBDorothea Böken
- Catherine K. XuCXCatherine K. Xu
- Emre FertanEFEmre Fertan
- Jonathan C. BreiterJBJonathan C. Breiter
- Lexie E. BerkowiczLBLexie E. Berkowicz
- Laura Sancho SalazarLSLaura Sancho Salazar
- Alex Von SchulzeASAlex Von Schulze
- Ewa A. AndrzejewskaEAEwa A. Andrzejewska
- Emma E. BrockEBEmma E. Brock
Preprint
Abstract
Protein aggregates are a pathological hallmark across neurodegenerative diseases. Yet, the disconnect between molecular-level aggregation and the emergence of disease severely limits mechanistic understanding of neurodegeneration. Here, we bridge this disconnect by showing that a cellular tipping point emerges as a universal feature across diseases from the competition between aggregate accumulation and removal. We map the resulting cellular phase transition with our high-throughput live-cell assay, measuring the tipping point that separates healthy cells from those with large aggregate loads. Using super-resolution imaging of brain tissue from Alzheimer’s and Parkinson’s disease, we quantify how the balance of accumulation and removal is shifted in disease. We validate our framework by predicting how designed aggregation inhibitors shift the tipping point to restore cellular homeostasis. Our results provide a mechanistic framework connecting molecular-level aggregation to disease, paving the way for a quantitative, unified understanding of neurodegeneration and enabling predictions of therapeutic efficacy.Keywords
Funding Information
- National Institute for Health Research Cambridge Biomedical Research Centre (NIHR203312)
- Medical Research Council (MC_UU_00030/14; MR/T033371/1)
- National Institute of General Medical Sciences of the National Institutes of Health (R01GM130927)
This publication has 65 references indexed in Scilit:
- Single‐Molecule Characterization and Super‐Resolution Imaging of Alzheimer's Disease‐Relevant Tau Aggregates in Human SamplesAngewandte Chemie International Edition, 2024
- Tau seeding without tauopathyJournal of Biological Chemistry, 2023
- Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer DiseaseJAMA Neurology, 2023
- Super-resolution imaging unveils the self-replication of tau aggregates upon seedingCell Reports, 2023
- Cholesterol determines the cytosolic entry and seeded aggregation of tauCell Reports, 2022
- Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker researchAlzheimer's & Dementia, 2021
- Quantifying Nucleation In Vivo Reveals the Physical Basis of Prion-like Phase BehaviorMolecular Cell, 2018
- Protein homeostasis and aging: The importance of exquisite quality controlAgeing Research Reviews, 2011
- Alzheimer's disease in Down syndrome: Neurobiology and riskMental Retardation and Developmental Disabilities Research Reviews, 2007
- α-synuclein locus duplication as a cause of familial Parkinson's diseaseThe Lancet, 2004